KalVista Pharmaceuticals (STU:4XC1) Short-Term Capital Lease Obligation : €1.09 Mil (As of Jan. 2024)

View and export this data going back to 2016. Start your Free Trial

What is KalVista Pharmaceuticals Short-Term Capital Lease Obligation?

KalVista Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was €1.09 Mil.

KalVista Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Jul. 2023 (€1.01 Mil) to Oct. 2023 (€1.09 Mil) and increased from Oct. 2023 (€1.09 Mil) to Jan. 2024 (€1.09 Mil).

KalVista Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Apr. 2021 (€0.72 Mil) to Apr. 2022 (€0.91 Mil) and increased from Apr. 2022 (€0.91 Mil) to Apr. 2023 (€0.99 Mil).

KalVista Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for KalVista Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KalVista Pharmaceuticals Short-Term Capital Lease Obligation Chart

KalVista Pharmaceuticals Annual Data

Trend

Dec14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.54

0.72

0.91

0.99

KalVista Pharmaceuticals Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.98	0.99	1.01	1.09	1.09

KalVista Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

KalVista Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of KalVista Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

KalVista Pharmaceuticals (STU:4XC1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » KalVista Pharmaceuticals Inc (STU:4XC1) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

KALV:USA 4XC1:Germany

Address

55 Cambridge Parkway, Suite 901 East, Cambridge, MA, USA, 02142

Website

https://www.kalvista.com

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

KalVista Pharmaceuticals (STU:4XC1) Headlines

No Headlines